Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF SEPTEMBER 29, 2010 FBO #3231
AWARD

R -- RECOVERY – Biospecimen Core Resources (BCR) Providing Biospecimen Processing Services to The Cancer Genome Atlas (TCGA)

Notice Date
9/27/2010
 
Notice Type
Award Notice
 
NAICS
541990 — All Other Professional, Scientific, and Technical Services
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, Maryland, 21702
 
ZIP Code
21702
 
Solicitation Number
N02-CO-07013-64
 
Archive Date
10/9/2010
 
Point of Contact
James D Carder, Phone: (301) 228-4221, Robin M. Irving, Phone: (301) 228-4220
 
E-Mail Address
jc490y@nih.gov, irvingr@mail.nih.gov
(jc490y@nih.gov, irvingr@mail.nih.gov)
 
Small Business Set-Aside
N/A
 
Award Number
HHSN261201000048C
 
Award Date
9/24/2010
 
Awardee
International Genomics Consortium, 445 North Fifth Street, Phoenix, Arizona 85004-2101, United States
 
Award Amount
The total dollar value of this contract, including all options if exercised, is $37,521,407.
 
Description
This contract is to provide support services for The Cancer Genome Atlas (TCGA) Program for the National Cancer Institute (NCI). The Base Period is for eighteen (18) months, with three successive one (1) year options and one (1) six (6) month option in the following amounts: Base Period $12,251,131 (ARRA FUNDING), Option Period 1 $7,574,995; Option Period 2 $7,337,839; Option Period 3 $6,967,998; and Option Period Four $3,389,444. The total dollar value of this contract, including all options if exercised, is $37,521,407. The specific purpose of this project is to establish two (2) Biospecimen Core Resource(s) (BCRs) sites for receiving tissue and data from the multiple the Tissue Source Site (TSS) networks for storage, quality control, processing into molecular analytes, shipping of high quality analytes to genome characterization and sequencing centers, and other support efforts to The Cancer Genome Atlas (TCGA) Program. Rationale for other than fixed-price contracting action is as follows: The nature of the project requirements described in the Statement of Work (SOW) do not contain precise specifications to warrant a fixed-price mechanism. Further, difficulty in estimating costs with accuracy does not lend this requirement to a fixed-price mechanism. Therefore, a cost reimbursement type contract is appropriate for this acquisition. In accordance with FAR 16.3, Cost-reimbursement contracts are suitable for use only when uncertainties involved in contract performance do not permit costs to be estimated with sufficient accuracy to use any type of fixed-price contract. Sufficient safeguards are included in the contract to ensure that costs are allowable, allocable, fair, and reasonable.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF2/N02-CO-07013-64/listing.html)
 
Place of Performance
Address: Contractor Facility, United States
 
Record
SN02298232-W 20100929/100927234923-3e0c10781556db167211a54451c29808 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.